Q3 2026 NU SKIN ENTERPRISES EARNINGS CONFERENCE CALL - NU SKIN ENTERPRISES INC

Explicit Guidance:

• Q4 2026 Revenue: $310–$340 million (approx. 1% foreign currency tailwind expected).
• Q4 2026 Earnings Per Share (EPS): Reported $0.05–$0.15; Adjusted $0.11–$0.21.
• Full Year 2026 Revenue: $1.26–$1.29 billion (approx. 1% foreign currency headwind expected).
• Full Year 2026 Adjusted EPS: $0.55–$0.65.
• Full Year 2026 Effective Tax Rate: Approximately 39%.
• Full Year 2026 Reported EPS: Negative $5.08 to negative $4.98 (impacted by non-cash goodwill impairment and deferred tax valuation allowance).
• Transition Costs: Approximately $5 million in remaining cash-based organizational transition costs anticipated in Q4 2026 (excluded from adjusted guidance).

Business-Segment Outlook:

• Q4 2026 Performance: Anticipation of sequential revenue growth driven by holiday season customer and affiliate engagement.
• RISE Platform: Expected to sustain strong year-over-year revenue growth; no specific quantitative targets provided for future periods.
• Prism.io (Anti-Aging Tech): 41,000 devices deployed globally with 4.5 million scans as of Q3 2026; scan-to-purchase conversion rate doubled to 10% following August 2026 Version 2.0 AI update. Management expects conversion rates to increase significantly as AI intelligence improves and user engagement deepens.
• LifePak Sales: Grew nearly 3% year-to-date; expected to benefit from the integrated anti-aging platform's recurring consumption model.
• Core Nu Skin Gross Margin: Currently 76.6% (Q3 2026); target is improvement via pricing discipline and product mix optimization.
• Core Selling Expense: Targeting a long-term level of approximately 40% of revenue.

Market and Competitive Outlook:

• Demand Trends: Management views current market pressures as structural, necessitating a shift from short-term promotions to sustained programmatic approaches for channel momentum.
• Channel Evolution: Shift toward social media-based acquisition (links, DMs) requires affiliates to master new digital skills; sales leaders are being retrained to meet these evolving requirements.
• Pricing Strategy: Implementation of "good, better, best" recommendation tiers to address inflation concerns and offer flexible pricing options to consumers.

Macro / Industry Outlook:

• Foreign Currency: Q4 2026 expected tailwind (~1%); Full Year 2026 expected headwind (~1%).
• Inflation: Identified as a heavy current pressure; the Prism platform's pricing flexibility is a direct countermeasure.
• Geopolitical/Supply: No specific macro risks regarding tariffs or regulation mentioned, but manufacturing relocation is being executed to optimize supply chain responsiveness.

Strategic Initiatives:

• India Market Launch: Formal launch scheduled for the first half of 2027; currently in pre-marketing preparation phase with focus on operational, product, and commercial readiness.
• Product Pipeline: New anti-aging innovations, with a specific focus on women's health, rolling out mid-2027.
• Operating Model Restructure: Implementation of an "East-West" organizational structure to align resources, improve speed to market, and optimize fixed costs.
• Manufacturing Strategy: Relocating production closer to end-markets (U.S. for Western markets, China for Eastern markets) to improve gross margins and fixed cost optimization over time.
• Sales Channel Development: Launching leadership training programs (e.g., with Eric Worre) and refining compensation/incentive roadmaps for 2027 to focus on customer acquisition and sustainable skill building.

Risks and Headwinds to Outlook:

• Guidance Variance: Potential for actual results to differ materially due to the execution risks associated with the East-West operating model transition.
• Market Conditions: Ongoing pressures in the core business and broader revenue environment could impact customer acquisition and retention metrics.
• Foreign Exchange: Fluctuations in currency rates remain a volatility factor for both revenue and earnings.
• Execution Timeline: The India launch is a long-term bet; success depends on refining preparations during the pre-launch phase, with execution risk in the 2027 timeline.

Management Tone on the Future:

• Confidence Level: Cautiously optimistic; expressed confidence that disciplined execution of strategic priorities will "position us for sustainable growth in the periods ahead."
• Strategic Focus: Emphasis on "long-term perspective" for India and structural improvements over short-term fixes.
• Channel Sentiment: Acknowledges current customer and sales metrics are "under pressure" but views recent investments in leadership development as essential for rebuilding the "foundation for more sustainable performance."
• Differentiation: High confidence in the Prism platform's ability to create a "differentiated experience" and deepen engagement, viewing the current 10% conversion rate as an "early stage" with significant upside potential.

Miscellaneous:

• Capital Allocation: $137.3 million remaining under the current share repurchase authorization; $2.9 million returned via dividends in Q3 2026.
• Balance Sheet: $164.9 million cash and equivalents; $203.7 million total debt at quarter end.